{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T06:02:47Z","timestamp":1787896967934,"version":"build-2784847793"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008367","name":"Universit\u00e9 Libre de Bruxelles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.coviro.2019.07.004","type":"journal-article","created":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T23:08:02Z","timestamp":1567897682000},"page":"63-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Applications of CRISPR\/Cas9 tools in deciphering the mechanisms of HIV-1 persistence"],"prefix":"10.1016","volume":"38","author":[{"given":"Roxane","family":"Verdikt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Darcis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Ait-Ammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Van Lint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2019.07.004_bib0005","doi-asserted-by":"crossref","first-page":"a007161","DOI":"10.1101\/cshperspect.a007161","article-title":"HIV-1 antiretroviral drug therapy","volume":"2","author":"Arts","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.coviro.2019.07.004_bib0010","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/jama.279.6.450","article-title":"Improved survival among HIV-infected individuals following initiation of antiretroviral therapy","volume":"279","author":"Hogg","year":"1998","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.coviro.2019.07.004_bib0015","doi-asserted-by":"crossref","first-page":"15109","DOI":"10.1073\/pnas.96.26.15109","article-title":"HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression","volume":"96","author":"Davey","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2019.07.004_bib0020","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nri3262","article-title":"Towards an HIV cure: a global scientific strategy","volume":"12","author":"Deeks","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coviro.2019.07.004_sbref0025","series-title":"HIV-1 Latency. Current Topics in Microbiology and Immunology","doi-asserted-by":"crossref","first-page":"vol 417","DOI":"10.1007\/82_2017_74","article-title":"Molecular control of HIV and SIV latency","author":"Darcis","year":"2017"},{"key":"10.1016\/j.coviro.2019.07.004_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-4690-10-67","article-title":"HIV-1 transcription and latency: an update","volume":"10","author":"Van Lint","year":"2013","journal-title":"Retrovirology"},{"key":"10.1016\/j.coviro.2019.07.004_bib0035","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/ni.3152","article-title":"HIV reservoirs as obstacles and opportunities for an HIV cure","volume":"16","author":"Chun","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coviro.2019.07.004_bib0040","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S2055-6640(20)30490-8","article-title":"HIV persistence in the setting of antiretroviral therapy: when, where and how does HIV hide?","volume":"1","author":"Kulpa","year":"2015","journal-title":"J Virus Erad"},{"key":"10.1016\/j.coviro.2019.07.004_bib0045","first-page":"ciz108","article-title":"Na\u00efve CD4+ T cells harbor a large inducible reservoir of latent, replication-competent HIV-1","author":"Zerbato","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coviro.2019.07.004_bib0050","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.celrep.2017.09.081","article-title":"Identification of genetically intact HIV-1 proviruses in specific CD4+ T cells from effectively treated participants","volume":"21","author":"Hiener","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.coviro.2019.07.004_bib0055","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.immuni.2012.08.010","article-title":"Redefining the viral reservoirs that prevent HIV-1 eradication","volume":"37","author":"Eisele","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.coviro.2019.07.004_sbref0060","first-page":"872","article-title":"Targeting the latent reservoir for HIV-1","volume":"48","author":"Sengupta","year":"2018","journal-title":"Immun Rev"},{"key":"10.1016\/j.coviro.2019.07.004_bib0065","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.chom.2012.07.005","article-title":"As good as it gets? the problem of HIV persistence despite antiretroviral drugs","volume":"12","author":"Sigal","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2019.07.004_sbref0070","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/COH.0000000000000293","article-title":"Tissue reservoirs of HIV","volume":"11","author":"Wong","year":"2016","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.coviro.2019.07.004_bib0075","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/QAD.0000000000001290","article-title":"Reactivation capacity by latency-reversing agents ex vivo correlates with the size of the HIV-1 reservoir","volume":"31","author":"Darcis","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.coviro.2019.07.004_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13148-016-0185-6","article-title":"Development of 5'LTR DNA methylation of latent HIV-1 provirus in cell line models and in long-term-infected individuals","volume":"8","author":"Trejbalova","year":"2016","journal-title":"Clin Epigenet"},{"key":"10.1016\/j.coviro.2019.07.004_sbref0085","doi-asserted-by":"crossref","DOI":"10.1126\/science.1258096","article-title":"The new frontier of genome engineering with CRISPR-Cas9","volume":"346","author":"Doudna","year":"2014","journal-title":"Science (80-)"},{"key":"10.1016\/j.coviro.2019.07.004_bib0090","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science (80-)"},{"key":"10.1016\/j.coviro.2019.07.004_bib0095","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1232033","article-title":"RNA-guided human genome engineering via Cas9","volume":"339","author":"Mali","year":"2013","journal-title":"Science (80-)"},{"key":"10.1016\/j.coviro.2019.07.004_sbref0100","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","article-title":"Development and applications of CRISPR-Cas9 for genome engineering","volume":"157","author":"Hsu","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2019.07.004_bib0105","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/nbt.3659","article-title":"Applications of CRISPR technologies in research and beyond","volume":"34","author":"Barrangou","year":"2016","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.coviro.2019.07.004_bib0110","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.tibs.2015.07.003","article-title":"Ready, pause, go: regulation of RNA polymerase II pausing and release by cellular signaling pathways","volume":"40","author":"Liu","year":"2015","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.coviro.2019.07.004_bib0115","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.chom.2011.11.002","article-title":"The control of HIV transcription: keeping RNA polymerase II on track","volume":"10","author":"Ott","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2019.07.004_bib0120","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/j.1460-2075.1996.tb00449.x","article-title":"Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation","volume":"15","author":"Van Lint","year":"1996","journal-title":"EMBO J"},{"key":"10.1016\/j.coviro.2019.07.004_bib0125","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1128\/MCB.01013-13","article-title":"Negative elongation factor is required for the maintenance of proviral latency but does not induce promoter-proximal pausing of RNA polymerase II on the HIV long terminal repeat","volume":"34","author":"Jadlowsky","year":"2014","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.coviro.2019.07.004_bib0130","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.molcel.2010.04.012","article-title":"HIV-1 Tat assembles a multifunctional transcription elongation complex and stably associates with the 7SK snRNP","volume":"38","author":"Sobhian","year":"2010","journal-title":"Mol Cell"},{"key":"10.1016\/j.coviro.2019.07.004_bib0135","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.molcel.2010.04.013","article-title":"HIV-1 Tat and host AFF4 recruit two transcription elongation factors into a bifunctional complex for coordinated activation of HIV-1 transcription","volume":"38","author":"He","year":"2010","journal-title":"Mol Cell"},{"key":"10.1016\/j.coviro.2019.07.004_bib0140","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0092-8674(00)80939-3","article-title":"A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA","volume":"92","author":"Wei","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2019.07.004_bib0145","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.1093\/nar\/gkv541","article-title":"Gene target specificity of the Super Elongation Complex (SEC) family: how HIV-1 Tat employs selected SEC members to activate viral transcription","volume":"43","author":"Lu","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.coviro.2019.07.004_bib0150","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1128\/MCB.00994-15","article-title":"A minor subset of super elongation complexes plays a predominant role in reversing HIV-1 latency","volume":"36","author":"Li","year":"2016","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.coviro.2019.07.004_sbref0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007498","article-title":"Reiterative Enrichment and Authentication of CRISPRi Targets (REACT) identifies the proteasome as a key contributor to HIV-1 latency","volume":"15","author":"Li","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2019.07.004_bib0160","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2013.06.044","article-title":"CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes","volume":"154","author":"Gilbert","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2019.07.004_bib0165","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1742-4690-10-120","article-title":"Proteasome inhibitors act as bifunctional antagonists of human immunodeficiency virus type 1 latency and replication","volume":"10","author":"Miller","year":"2013","journal-title":"Retrovirology"},{"key":"10.1016\/j.coviro.2019.07.004_bib0170","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.chom.2008.04.008","article-title":"HIV-1 accessory proteins \u2013 ensuring viral survival in a hostile environment","volume":"3","author":"Malim","year":"2008","journal-title":"Cell Host Microbe Rev"},{"key":"10.1016\/j.coviro.2019.07.004_sbref0175","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nrmicro.2016.162","article-title":"Nuclear landscape of HIV-1 infection and integration","volume":"15","author":"Lusic","year":"2017","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.coviro.2019.07.004_bib0180","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1172\/JCI124291","article-title":"Intact HIV-1 proviruses accumulate at distinct chromosomal positions during prolonged antiretroviral therapy","volume":"129","author":"Einkauf","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coviro.2019.07.004_bib0185","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1086\/510915","article-title":"Recurrent HIV\u20101 integration at the BACH2 locus in resting CD4+ T cell populations during effective highly active antiretroviral therapy","volume":"195","author":"Ikeda","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2019.07.004_bib0190","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1126\/science.1254194","article-title":"Specific HIV integration sites are linked to clonal expansion and persistence of infected cells","volume":"345","author":"Maldarelli","year":"2014","journal-title":"Science (80-)"},{"key":"10.1016\/j.coviro.2019.07.004_bib0195","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1126\/science.1256304","article-title":"Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection","volume":"345","author":"Wagner","year":"2014","journal-title":"Science (80-)"},{"key":"10.1016\/j.coviro.2019.07.004_bib0200","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.chom.2016.04.010","article-title":"What integration sites tell us about HIV persistence","volume":"19","author":"Hughes","year":"2016","journal-title":"Cell Host Microbe Perspect"},{"key":"10.1016\/j.coviro.2019.07.004_bib0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-00609-1","article-title":"HIV-1-mediated insertional activation of STAT5B and BACH2 trigger viral reservoir in T regulatory cells","volume":"8","author":"Cesana","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2019.07.004_bib0210","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1073\/pnas.1522675113","article-title":"Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo","volume":"113","author":"Simonetti","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2019.07.004_bib0215","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1093\/emboj\/cdg188","article-title":"HIV reproducibly establishes a latent infection after acute infection of T cells in vitro","volume":"22","author":"Jordan","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.coviro.2019.07.004_bib0220","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nsmb.3328","article-title":"Position effects influence HIV latency reversal","volume":"24","author":"Chen","year":"2017","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.coviro.2019.07.004_bib0225","doi-asserted-by":"crossref","first-page":"4716","DOI":"10.1128\/JVI.03478-12","article-title":"A doubly fluorescent HIV-1 reporter shows that the majority of integrated HIV-1 is latent shortly after infection","volume":"87","author":"Dahabieh","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2019.07.004_bib0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-4690-10-90","article-title":"HIV latency and integration site placement in five cell-based models","volume":"10","author":"Sherrill-Mix","year":"2013","journal-title":"Retrovirology"},{"key":"10.1016\/j.coviro.2019.07.004_bib0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.34655","article-title":"Distinct chromatin functional states correlate with HIV latency reactivation in infected primary CD4+ T cells","volume":"7","author":"Battivelli","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.coviro.2019.07.004_bib0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1003834","article-title":"An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients","volume":"9","author":"Spina","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2019.07.004_bib0245","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nature20565","article-title":"In vivo genome editing via CRISPR\/Cas9 mediated homology-independent targeted integration","volume":"540","author":"Suzuki","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2019.07.004_sbref0250","article-title":"CRISPR-Cas9-based genome engineering to generate Jurkat reporter models for HIV-1 infection with selected proviral integration sites","volume":"14","author":"Bialek","year":"2018","journal-title":"J Vis Exp"},{"key":"10.1016\/j.coviro.2019.07.004_bib0255","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nature14226","article-title":"Nuclear architecture dictates HIV-1 integration site selection","volume":"521","author":"Marini","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2019.07.004_bib0260","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.chom.2013.05.006","article-title":"Proximity to PML nuclear bodies regulates HIV-1 latency in CD4+ T cells","volume":"13","author":"Lusic","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2019.07.004_bib0265","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.gpb.2018.10.001","article-title":"Progress and challenges for live-cell imaging of genomic loci using CRISPR-based platforms","volume":"17","author":"Wu","year":"2019","journal-title":"Genom Proteom Bioinf"},{"key":"10.1016\/j.coviro.2019.07.004_sbref0270","doi-asserted-by":"crossref","first-page":"12896","DOI":"10.1021\/acs.analchem.7b03584","article-title":"Live visualization of HIV-1 proviral DNA using a dual-color-labeled CRISPR system","volume":"89","author":"Ma","year":"2017","journal-title":"Anal Chem"},{"key":"10.1016\/j.coviro.2019.07.004_sbref0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/v10040157","article-title":"Tackling HIV persistence: pharmacological versus CRISPR-based shock strategies","volume":"10","author":"Darcis","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.coviro.2019.07.004_bib0280","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.virusres.2017.07.020","article-title":"CRISPR-Cas based antiviral strategies against HIV-1","volume":"244","author":"Wang","year":"2018","journal-title":"Virus Res"},{"key":"10.1016\/j.coviro.2019.07.004_bib0285","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.dnarep.2016.05.001","article-title":"The democratization of gene editing: insights from site-specific cleavage and double-strand break repair","volume":"44","author":"Jasin","year":"2016","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.coviro.2019.07.004_bib0290","doi-asserted-by":"crossref","first-page":"10437","DOI":"10.1073\/pnas.1512503112","article-title":"Generation of knock-in primary human T cells using Cas9 ribonucleoproteins","volume":"112","author":"Schumann","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2019.07.004_bib0295","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nm.4337","article-title":"HIV persistence in macrophages","volume":"23","author":"Stevenson","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.coviro.2019.07.004_bib0300","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nbt.2916","article-title":"Genome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease","volume":"32","author":"Kuscu","year":"2014","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.coviro.2019.07.004_bib0305","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/mt.2016.24","article-title":"CRISPR-Cas9 can inhibit HIV-1 replication but NHEJ repair facilitates virus escape","volume":"24","author":"Wang","year":"2016","journal-title":"Mol Ther"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625719300641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625719300641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:21:31Z","timestamp":1783632091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625719300641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":61,"alternative-id":["S1879625719300641"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2019.07.004","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Applications of CRISPR\/Cas9 tools in deciphering the mechanisms of HIV-1 persistence","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2019.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}